Results 161 to 170 of about 55,413 (307)

Dasatinib: A Novel Etiology of Reversible Cerebellar Ataxia. [PDF]

Ann Indian Acad Neurol
Mustafa F, Garg D, Agarwal A, Srivastava AK.   +3 more
europepmc   +1 more source

POLG‐Related Parkinsonism with Good Response to Deep Brain Stimulation

Movement Disorders Clinical Practice, EarlyView.
Evdokia Efthymiou, Fabian Büchele, Sujitha Mahendran, Lennart Stieglitz, Bettina Balint   +4 more
wiley   +1 more source

Altered Cerebrospinal Fluid Tryptophan–Kynurenine Pathway Metabolism in Multiple System Atrophy

Movement Disorders, EarlyView.
Abstract Background Alterations in tryptophan–kynurenine (TRP‐KYN) metabolism, which is associated with neuroinflammation, remain unclear in multiple system atrophy (MSA). Objective The aim was to investigate cerebrospinal fluid (CSF) TRP metabolites in MSA and their associations with other biomarkers.
Ryunosuke Nagao, Kazuya Kawabata, Yasuaki Mizutani, Sayuri Shima, Akihiro Ueda, Mizuki Ito, Yasuhiro Maeda, Akihiro Mouri, Hirohisa Watanabe   +8 more
wiley   +1 more source

Case report: anti-NMDAR encephalitis with cerebellar ataxia as the initial manifestation. [PDF]

BMC Neurol
Wang Y, Cui L, Zhang N.
europepmc   +1 more source

Ataxia and the olivo-cerebellar module

, 2010
Ataxia is a neurological symptom characterized by abnormal movement, due to cerebellar malfunction. Although the cause of the malfunction varies, from mutations in calcium or potassium channels to progressive degeneration of cerebellar tissue, the ...
Yarom, Yosef, Lefler, Yaara, Yaron-Jakoubovitch, Anat, Libster, Avraham M.   +3 more
core  

Phenotypic Clues in Infantile‐Onset Parkinsonism‐Dystonia‐2: A Treatable Neurotransmitter Disorder

Movement Disorders Clinical Practice, EarlyView.
Sangeetha Yoganathan, Haya S. AlFaris, Lindsey Vogt, Michele Eid, Anika Menetrey, Sayoni Roy Chowdhury, Dawn Codeiro, Pradeep Krishnan, Liali Aljouda, Emily W.Y. Tam, Carolina Gorodetsky   +10 more
wiley   +1 more source

Deep Brain Stimulation for Cerebellar Ataxia: A Systematic Review on Indications, Targets and Outcomes. [PDF]

Cerebellum
Mantovani G, Antenucci P, Collautti E, Gozzi A, Sensi M, Cavallo MA, Scerrati A.   +6 more
europepmc   +1 more source

Arts Syndrome and Involuntary Eye Movements

Movement Disorders Clinical Practice, EarlyView.
Victor Rebelo Procaci, Victor Augusto Vanderlinde Camara, Flavio Moura Rezende Filho, José Luiz Pedroso, Orlando Graziani Povoas Barsottini   +4 more
wiley   +1 more source

Modulation of the Stress Granule Component Carhsp1 Mitigates Disease‐Associated Deficits in Spinocerebellar Ataxia Type 3 Mouse Models

Movement Disorders, EarlyView.
Abstract Background Spinocerebellar ataxia type 3 (SCA3) is a polyglutamine (polyQ) neurogenerative disorder that results from CAG trinucleotide repeat expansions in the ATXN3 gene, leading to toxic protein aggregate formation and cellular pathway dysfunction.
Tiago Moreira‐Gomes, Adriana Marcelo, Ana Teresa Rajado, Rafael G. Costa, Ricardo Afonso‐Reis, Cristiana R. Madeira, Inês T. Afonso, David V.C. Brito, Adriana A. Vaz, Clévio Nóbrega   +9 more
wiley   +1 more source

Anti-Sez6L2 antibody-associated autoimmune cerebellar ataxia: a rare case with implications of rituximab therapy. [PDF]

Neurol Sci
Gao Y, Duan R.
europepmc   +1 more source